Language : English
万小敏

Journal Publications

First-Line Atezolizumab in Addition to Bevacizumab Plus Chemotherapy for Metastatic, Nonsquamous Non–Small Cell Lung Cancer: A United States–Based Cost-Effectiveness Analysis

Journal:Cancer

Co-author:Peng Liubao, Zhang Yucong, Zeng Xiaohui, Tan Chongqing, Luo Xia, Wan Xiaomin

Volume:125

Issue:20

Page Number:3526-3534

Translation or Not:no